{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:22:16Z","timestamp":1762323736272,"version":"3.37.3"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1124\/dmd.114.058511","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T04:21:07Z","timestamp":1405570867000},"page":"1617-1626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Differential Effect of Liver Cirrhosis on the Pregnane X Receptor\u2013Mediated Induction of CYP3A1 and 3A2 in the Rat"],"prefix":"10.1016","volume":"42","author":[{"given":"Sara","family":"De Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Gabbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Albertin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Martina","family":"Sfriso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Mescoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Albertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Paliuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Bova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Palatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.114.058511_bib1","first-page":"431","article-title":"Adrenomedullin and vascular endothelium growth factor genes are overexpressed in the regenerating rat adrenal cortex, and AM and VEGF reciprocally enhance their mRNA expression in cultured rat adrenocortical cells","volume":"16","author":"Albertin","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1124\/dmd.114.058511_bib2","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1345\/aph.1E508","article-title":"Predicting inhibitory drug-drug interactions and evaluating drug interaction reports using inhibition constants","volume":"39","author":"Bachmann","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.114.058511_bib3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1124\/dmd.106.009977","article-title":"Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymes","volume":"34","author":"Carr","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.058511_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jbt.2570100604","article-title":"Differential regulation of cytochrome P450 3A1 and P450 3A2 in rat liver following dexamethasone treatment","volume":"10","author":"Choudhuri","year":"1995","journal-title":"J Biochem Toxicol"},{"key":"10.1124\/dmd.114.058511_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/00498250701245250","article-title":"Cytochrome P450 probe substrate metabolism kinetics in Sprague Dawley rats","volume":"37","author":"Chovan","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.114.058511_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/abbi.1993.1154","article-title":"Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats","volume":"301","author":"Cooper","year":"1993","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.114.058511_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.1998.00679.x","article-title":"Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes","volume":"45","author":"Eagling","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.114.058511_bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0192623310374332","article-title":"Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man","volume":"38","author":"Ennulat","year":"2010","journal-title":"Toxicol Pathol"},{"key":"10.1124\/dmd.114.058511_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/icb.1984.29","article-title":"Microsomal protein synthesis and induction of cytochrome P-450 in cirrhotic rat liver","volume":"62","author":"Farrell","year":"1984","journal-title":"Aust J Exp Biol Med Sci"},{"key":"10.1124\/dmd.114.058511_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2133\/dmpk.DMPK-12-RG-035","article-title":"Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar rats","volume":"27","author":"Floreani","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.114.058511_bib11","doi-asserted-by":"crossref","first-page":"e61983","DOI":"10.1371\/journal.pone.0061983","article-title":"Severe liver cirrhosis markedly reduces AhR-mediated induction of cytochrome P450 in rats by decreasing the transcription of target genes","volume":"8","author":"Floreani","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/dmd.114.058511_bib12","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0006-2952(01)00820-6","article-title":"In vivo up-regulation of aryl hydrocarbon receptor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in a dioxin-resistant rat model","volume":"62","author":"Franc","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.114.058511_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00003088-200038060-00003","article-title":"Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans","volume":"38","author":"Fuhr","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.114.058511_bib14","first-page":"120","article-title":"Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease","volume":"21","author":"George","year":"1995","journal-title":"Hepatology"},{"key":"10.1124\/dmd.114.058511_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/abbi.1996.0327","article-title":"Induction of the male-specific cytochrome P450 3A2 in female rats by phenytoin","volume":"332","author":"Ghosal","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.114.058511_bib16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0022-3565(25)23168-8","article-title":"Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples","volume":"256","author":"Guengerich","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.058511_bib18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1080\/00498250701534893","article-title":"Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations","volume":"37","author":"Hewitt","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.114.058511_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev.me.33.020182.000553","article-title":"Major drug interactions: effect of liver disease, alcohol, and malnutrition","volume":"33","author":"Hoyumpa","year":"1982","journal-title":"Annu Rev Med"},{"key":"10.1124\/dmd.114.058511_bib20","first-page":"48","article-title":"Two-stage glucocorticoid induction of CYP3A23 through both the glucocorticoid and pregnane X receptors","volume":"58","author":"Huss","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.114.058511_bib21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.114.058511_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2005.11.019","article-title":"Generation of specific antibodies and their use to characterize sex differences in four rat P450 3A enzymes following vehicle and pregnenolone 16alpha-carbonitrile treatment","volume":"446","author":"Jan","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.114.058511_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11095-004-1190-6","article-title":"Altered pharmacokinetics of paclitaxel in experimental hepatic or renal failure","volume":"22","author":"Jiko","year":"2005","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.114.058511_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1440-1746.1992.tb00940.x","article-title":"Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease","volume":"7","author":"Jim\u00e9nez","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1124\/dmd.114.058511_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0006-2952(01)00843-7","article-title":"Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat","volume":"63","author":"Kobayashi","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.114.058511_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1124\/dmd.114.058511_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/chromsci\/40.7.397","article-title":"A high-performance-liquid-chromatography-based method for the determination of hydroxylated testosterone metabolites formed in vitro in liver microsomes from gray seal (Halichoerus grypus)","volume":"40","author":"Li","year":"2002","journal-title":"J Chromatogr Sci"},{"key":"10.1124\/dmd.114.058511_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","article-title":"Inhibition and induction of cytochrome P450 and the clinical implications","volume":"35","author":"Lin","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.114.058511_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/clpt.1992.17","article-title":"The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease","volume":"51","author":"Lown","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.058511_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/abbi.1996.9752","article-title":"Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver","volume":"337","author":"Mahnke","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.114.058511_bib31","first-page":"578","article-title":"The effect of cirrhosis of the liver on microsomal detoxications and cytochrome P-450","volume":"50","author":"Marshall","year":"1969","journal-title":"Br J Exp Pathol"},{"key":"10.1124\/dmd.114.058511_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00003088-199529050-00005","article-title":"Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease: an update","volume":"29","author":"Morgan","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.114.058511_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pharmtox.41.1.297","article-title":"Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1","volume":"41","author":"Murray","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.114.058511_bib55","first-page":"24","article-title":"Induction and inhibition of CYPs and implications for medicine","volume":"20","author":"Murray","year":"1999","journal-title":"Mol Aspects Med"},{"key":"10.1124\/dmd.114.058511_bib34","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0022-3565(25)21306-4","article-title":"Enhanced inhibition of microsomal cytochrome P450 3A2 in rat liver during diltiazem biotransformation","volume":"279","author":"Murray","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.058511_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/clpt.2008.216","article-title":"Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function","volume":"85","author":"Orlando","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.058511_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.clpt.2006.01.012","article-title":"Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine","volume":"79","author":"Orlando","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.058511_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clpt.2003.09.007","article-title":"Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function","volume":"75","author":"Orlando","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.058511_bib38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie.\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.058511_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/157488408783329896","article-title":"Enzyme inhibition and induction in liver disease","volume":"3","author":"Palatini","year":"2008","journal-title":"Curr Clin Pharmacol"},{"key":"10.1124\/dmd.114.058511_bib40","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1517\/17425255.2010.503704","article-title":"The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update","volume":"6","author":"Palatini","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.114.058511_bib41","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2125.1996.03482.x","article-title":"Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications","volume":"41","author":"Park","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.114.058511_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0026-895X(24)12072-X","article-title":"Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators","volume":"58","author":"Pascussi","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.114.058511_bib44","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.114.058511_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0004-28032010000100013","article-title":"Melatonin protects the liver and erythrocytes against oxidative stress in cirrhotic rats","volume":"47","author":"Rosa","year":"2010","journal-title":"Arq Gastroenterol"},{"year":"1975","series-title":"Enzyme Kinetics","author":"Segel","key":"10.1124\/dmd.114.058511_bib46"},{"key":"10.1124\/dmd.114.058511_bib47","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.058511_bib48","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.drudis.2011.08.003","article-title":"Novel advances in cytochrome P450 research","volume":"16","author":"Singh","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1124\/dmd.114.058511_bib49","first-page":"837","article-title":"Clotrimazole is a selective and potent inhibitor of rat cytochrome P450 3A subfamily-related testosterone metabolism","volume":"29","author":"Turan","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.058511_bib50","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1124\/dmd.112.045245","article-title":"Down-regulation of hepatic CYP3A and CYP2C mediated metabolism in rats with moderate chronic kidney disease","volume":"40","author":"Velenosi","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.058511_bib51","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.114.058511_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1124\/dmd.32.6.647","article-title":"Validated assays for human cytochrome P450 activities","volume":"32","author":"Walsky","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.058511_bib53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1139\/y91-065","article-title":"Unimpaired induction of drug-metabolizing enzymes in hepatocytes isolated from rats with micronodular cirrhosis","volume":"69","author":"Wu","year":"1991","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/dmd.114.058511_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/jpet.104.067066","article-title":"Expression and induction of cytochromes p450 in rat white adipose tissue","volume":"311","author":"Yoshinari","year":"2004","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624114626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624114626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.114.058511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:36:02Z","timestamp":1739907362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624114626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0090955624114626"],"URL":"https:\/\/doi.org\/10.1124\/dmd.114.058511","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Effect of Liver Cirrhosis on the Pregnane X Receptor\u2013Mediated Induction of CYP3A1 and 3A2 in the Rat","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.114.058511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}